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Introduction A u to n o m ic  n e rvo u s  system  (ANS) d y s fu n c tio n  is associa ted  w ith  p ro g n o s is  in  c o ro n a ry  a r te ry  d isease (CAD). We a im e d  to  s tu d y  
th e  ca rd ia c  re h a b ili ta t io n  (CR) m o d u la tin g  e ffe c t on  a u to n o m ic  fu n c t io n , th ro u g h  h e a rt ra te  v a r ia b il ity  (HRV) and  h e a rt ra te  re co ve ry  (HRR) a fte r  exercise, 
in  CAD p a tie n ts  and  th e  associa ted  fac to rs .
Methods This s tu d y  is a re tro s p e c tiv e  ana lys is  o f  CAD p a tie n ts  in  s in us rh y th m  w h o  c o m p le te  a s in g le -c e n tre  CR p ro g ra m m e  and  c o m p le m e n ta ry  
e v a lu a tio n  in c lu d in g  HRV study, c a rd io p u lm o n a ry  exerc ise te s tin g , e ch o ca rd io g ra m .
Results O ur sa m p le  in c lu d e d  142 CAD p a tie n ts  (85.9%  m ale , 5 7 .8 ±  10.2 years, 85%  p o s t-a cu te  c o ro n a ry  syn d ro m e , 15%  s ta b le  C A D ).T here  w as a 
s ig n if ic a n t im p ro v e m e n t in  SDNN (1 2 0 .7 ± 40.7 ms vs 1 2 7 .6 ± 4 1 .5  m s; P = 0.019), re s tin g  HR (71.3 ± 1 0 .7  m i r r 1 vs 69.0  ± 1 0 .9  m in '1; P = 0 .0 1 5 )  and  HRR 
(23.8 ± 1 2 .3  m ir r ’ vs 27.1 ±  12.5 m i r r 1; P = 0.017) fo llo w in g  CR. Low er e ry th ro c y te  s e d im e n ta tio n  ra te  (OR 0.911; 95%  c o n fid e n ce  in te rv a l (Cl) 0 .838-0 .989 , 
P = 0.027), n o rm a l le f t  v e n tr ic u la r  (LV) fu n c t io n /m ild  LV sys to lic  d y s fu n c t io n  (OR 7.879; 9 5%  Cl 2 .753 -17 .351 , P = 0.009) a n d  SDNN lo w e r th a n  100 ms 
(OR 9.325; 95%  Cl 1 .775-48.978, P = 0.008) w ere  in d e p e n d e n tly  associa ted w ith  SDNN im p ro v e m e n t; q u it  sm o k in g  (OR 4.323; 95%  Cl 1.136-16.454, P = 0.014) 
and  a b n o rm a l HRR (OR 8 .023 ; 95%  Cl 1 .0 4 9 -6 4 .8 1 1 , P = 0.035) w e re  in d e p e n d e n t ly  associa ted  w ith  HRR im p ro v e m e n t.
Concl U S i o n  The card iac re h a b ilita t io n  p ro g ra m m e  in d u ce d  a p o s itive  m o d u la tio n  o f  th e  a u to n o m ic  fu n c t io n  in  CAD p a tie n ts , as re fle c te d  by SDNN 
and  HRR im p ro v e m e n t. Th is b e n e fit  w as assoc ia ted  w ith  ANS b a se lin e  d y s fu n c tio n , lo w e r sys tem ic  in fla m m a tio n , q u it  s m o k in g  and  n o rm a l LV fu n c t io n  to  
m ild  le ft  v e n tr ic u la r  sys to lic  d y s fu n c tio n .
Key W O  rd S Autonomic nervous system -  cardiac rehabilitation -  coronary artery disease; heart rate recovery -  heart rate variability.
INTRODUCTION
Autonomic nervous system (ANS) dysfunction is asso­
ciated with increased risk of morbidity and mortality in 
coronary artery disease (CAD), especially the risk of
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sudden cardiac death1'2. Previous data have shown an 
increase of sympathetic nervous activity and decrease of 
vagal tone after an acute coronary syndrome3,4. Auto­
nomic function may be assessed by relatively easy, 
non-invasive and cost-effective methods as resting heart 
rate (HR), heart rate variability (HRV), which analyse 
variation in the intervals between consecutive normal 
heart beats in milliseconds, and heart rate recovery (HRR) 
in exercise testing, that can be defined as the reduction 
in the heart rate from the rate at peak exercise to the rate 
one minute after the cessation of exercise5'6. Exercise- 
based cardiac rehabilitation (CR) has been associated with 
positive effects on autonomic function in CAD patients7'8, 
with HRV and HRR increases. This improvement in 
autonomic balance seems to correlate with increased
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exercise capacity, although few studies identified the 
parameters associated with ANS function modification.
We aimed to evaluate the modulating effect of CR on 
ANS function in CAD patients and to identify CAD risk 
factors and functional parameters associated with ANS 
function modification.
M E T H O D S
CAD patients who completed a phase-2 CR pro­
gramme and pre- and post-CR complementary evalua­
tion in our centre between January 2004 and January 
2013 were retrospectively evaluated. Patients with a 
pacemaker or atrial fibrillation and those who failed to 
attend at least 80% of the exercise sessions or did not 
complete all the complementary evaluation were 
excluded.
In ACS patients, pre-CR evaluation was performed 
in the first 2 weeks and the phase-2 CR programme was 
initiated between 2-4 weeks after discharge.
CR program m e
The CR programme consisted of 12 weeks of exercise 
training and lifestyle modification. The exercise training 
programme was performed three days per week (36 
sessions). Each exercise session included 10 minutes of 
warm-up, 30 minutes of aerobic exercise, 10 minutes of 
muscular strengthening and 5 minutes of cooling down 
and stretching. In the exercise prescription, the maximal 
exercise intensity was calculated as a percentage of the 
heart rate achieved at the anaerobic threshold in the 
treadmill exercise test. Individualized exercise prescrip­
tion was periodically adjusted to encourage a gradual 
increase in overall exercise performance.
In addition to the supervised exercise sessions, each 
patient was encouraged to exercise daily outside the 
formal exercise programme. All patients received dietary 
counselling by a nutrition specialist and selected patients 
received psychological support with self-management 
behaviour and underwent smoking cessation consult.
Com plem entary evaluation
The complementary evaluation consisted of an 
immediate pre- and post-CR HRV study, cardiopulmo­
nary exercise testing (CPT) and transthoracic echocar­
diography.
The HRV study was based on a 24-hour Holter 
recording by analysing the standard deviation of the NN 
(regular R-R) intervals (SDNN).
Before treadmill exercise testing, the resting haemo­
dynamic parameters (HR, systolic and diastolic blood
pressure) were measured. Resting HR was measured 
fifteen minutes before the onset of the stress test and 
after the patient had remained in a supine position for 
at least five minutes, in a quiet, mild-temperature envi­
ronment. With the patient seated, basal blood pressure 
was obtained by the mean of two measurements with 
a 1-min interval, using a digital automatic blood pres­
sure monitor. For systolic blood pressure, if there 
was more than 5 mmHg difference between the two 
readings, a third reading was obtained for the mean 
determination. Pharmacologic therapy, namely beta 
blockers, was maintained during pre- and post-CR 
evaluation. Non-smoking was strictly recommended 
on the day of the test. Then, a symptom-limited tread­
mill exercise test was conducted according to the mod­
ified Bruce protocol. The HR was monitored during 
the test and averaged every 10 seconds, using 12-lead 
electrocardiogram readings. Peak HR was considered 
the highest value achieved during the test. Blood pres­
sure was measured with a mercury sphygmomanom­
eter during the last 45 seconds of each stage of exercise, 
and in the last 15 seconds of exercise, nearing the end 
of the test. Peak systolic and diastolic blood pressures 
were recorded as the highest value achieved during the 
test. HRR was determined by calculating the difference 
between HR at peak exercise and HR at one minute 
after completion of the exercise. HR reserve was 
defined as the difference between peak and resting HR. 
Patients were instructed to sit after ending the test, and 
there was no cool-down. Pulmonary gas exchange 
analysis was performed throughout the test, including 
the measurement of oxygen uptake (V02) (SensorMed- 
ics Vmax 229, Yorba Linda, Calif.). Peak V 0 2 (pV02) 
was defined as the highest VO, attained during the final 
30 seconds of exercise. By transthoracic echocardiog­
raphy, the left ventricular ejection fraction (LVEF) 
(Simpson’s biplane method) and the E/A ratio were 
determined.
Statistical analysis
Discrete data are expressed as frequency (percentage) 
and continuous variables as mean±SD, or as median 
(minimum-maximum), when appropriate. Pre- and 
post-CR data were compared using the Student’s inde­
pendent f-test. The association of clinical and demo­
graphic characteristics, natriuretic peptides levels, CPT 
and echocardiographic parameters with SDNN and HRR 
improvement were studied using the chi-square test or 
the Student’s independent f-test and by backward mul­
tivariate logistic regression analysis, using significant 
variables. Data were analysed using the SPSS version 
17.0 statistical software and the level of statistical sig­
nificance was a = 0.05.
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RESULTS
O ur sample included 142 patients (85.9% male, 
57.8 ± 10.2 years), 85% post-acute coronary syndromes 
of which 91 patients (64%) were in the first month fol­
lowing ST-segment elevation myocardial infarction (76% 
had percutaneous coronary intervention complete revas­
cularization), and 15% had stable CAD. The clinical 
characteristics of the sample are presented in table 1. All 
patients were on antiplatelet therapy, statin, and a stable 
dose of beta blockers.
Pre- and post-CR data are presented in table 2. There 
were significant improvements in SDNN (A 6.9 ± 34.5 ms; 
120.7 ± 40.7 vs 127.6 ±41.5 ms, P = 0.019), resting HR (A 
2.4±11.0 m in”1; 71.3±  10.7 vs 69.0±  10.9 m in”1, 
P = 0.015), peak HR (A 2.8± 14.7 min”1; 138.3±21.0vs 
141.2 ±21.3 min-1, P = 0.027), HR reserve (A 3.3 ± 15.6 
m in '1; 67.0±20.1 vs 72.2±20.0 m in '1, P<0.001), HRR 
{A 3.3 ±15.6 m in '1; 23.8 ±12.3 vs 27.1 ±12.5 min"1, 
P = 0.017), pV 0 2 (A 1.8 ±6.0 mL.kg. m in '1; 25.6 ±6.8 vs 
27.5 ±7.2 mL.kg. m i n 1, P = 0.001) and E/A ratio 
(A -0.15±0.45; 1.20±0.54 vs 1.06±0.39, PcO.001).
The baseline independent factors associated with 
SDNN improvement were ESR (OR 0.911; 95% confi­
dence intervals (Cl) 0.838-0.989, P = 0.027), LVEF > 40% 
(OR 7.879; 95% Cl 2.753-37.351, P = 0.009) and SDNN 
< 100 ms (OR 9.325; 95% Cl 1.775-48.978, P = 0.008) as 
presented in table 3. The independent predictors of HRR 
improvement were baseline abnormal HRR (OR 8.023; 
95% Cl 1.049-64.811, P =  0.035) and quit smoking (OR 
4.323; 95% Cl 1.136-16.454, P= 0.014).
DISCUSSION
In this retrospective cohort we evaluated the modu­
lating effect of CR on ANS function in CAD patients 
and identified the clinical and functional parameters 
associated with ANS function modification.
Autonomic function was assessed using three differ­
ent techniques: resting HR, HRV and HRR, which have 
been previously validated5,6.
These parameters reflect the balance of sympathetic 
and parasympathetic effects, and their interactions. Each 
of these compounds had prognostic significance in pri­
mary and secondary prevention settings, even though 
a pathophysiological link has not been established. In 
the general population, the decrease of HRV and high 
resting HR can mean an increased risk of coronary heart 
disease, death and cardiac mortality7 9, whereas abnor­
mal HRR increases the relative risk of death10.
In patients with cardiovascular disease, ANS dysfunc­
tion is associated with worse prognosis2and might be a 
therapeutic target. Decreased HRV has been associated
T a b le  1 Clinical characteristics of the sample
A ge , m e a n  (SD), (years) 57 .8  (10.2)
M a le , n (% ) 122 (85,9)
S e d e n ta ry  (n o  re g u la r  ph ys ica l exe rc ise ), n (% ) 9 8  (69)
S m o k in g , n (% ) 6 0  (42)
D y s lip id a e m ia , n (% ) 8 6 (6 1 )
A r te r ia l h y p e rte n s io n , n  (% ) 71 (50)
BM I, m e a n  (SD) (K g /m 2) 27 .7  ± 3 . 8
O be s ity , n (% ) 3 8  (27)
D ia b e tes  m e llitu s ,  n  (% ) 2 3 (1 6 )
F a m ily  h is to ry  o f  c a rd io v a s c u la r d isease, n (% ) 21 (15)
P rio r M l, n (% ) 1 9 (1 3 )
SBP, m e a n  (SD) (m m h lg ) 121 ± 1 5
D8P, m e a n  (SD) (m m H g ) 72  ± 1 0
STEMI, n (% ) 91 (64)
NSTEMI, n (% ) 3 0 (2 1 )
S ta b le  CAD, n (% ) 2 1 (1 5 )
M u ltiv e s s e l d isease, n (% ) 5 8 (4 1 )
N YH A fu n c t io n  class 2  2, n (% ) 4 2  (30)
C re a tin in e  ( m g /d L , m e a n  (SD) 0 .9 3  ±  0 .23
eGFR (m L /m in  p e r  1 .72 m 2), m e a n  (SD) 101 ± 3 4
hs-CRP (m g /d L ),  m e a n  (SD) 13 .4  ± 2 4 .9
E ry th ro c y te  s e d im e n ta t io n  ra te  (m m /h ) ,  m e a n  (SD) 13.5  ±  17.9
F as ting  g ly c a e m ia , m e a n  (SD) (m g /d L )  110  +  26
T o ta l c h o le s te ro l, m e a n  (SD) (m g /d L )  153 ±  35
L D L -ch o le s te ro l, m e a n  (SD) (m g /d L )  9 6  ±  29
FH DL-cholesterol, m e a n  (SD) (m g /d L )  39  ±  11
T rig ly c e r id e s , m e a n  (SD) (m g /d L )  109 ±  57
LVEF, m e a n  (SD) (% ) 54 .3  ±  10.3
LVEDD, m e a n  (SD) (m m ) 54 .4  ±  8.5
LVESD, m e a n  (SD) (m m ) 35 .7  ± 9 .6
IVST, m e a n  (SD) (m m ) 10.3  ± 2 .3
PWT, m ea n  (SD) (m m ) 9 .5  ± 1 .8
LV m ass, m e a n  (SD) ( g /m 2) 99 .8  ±  35
Values are m ean ±  SD o r N (%). BMI: bod y  mass index, Ml: m yocardial infarction, 
SBP: systolic b lood  pressure, DBP: d iasto lic b lood  pressure, STEMI: ST-segment 
e levation  m yocardial infarction, NSTEMI: non-ST-segm ent elevation  m yocardial 
in farction , CAD, co rona ry  a rte ry  disease, NYHA: N ew  York H eart Association, 
eGFR: estim ated  g lom e ru la r filtra tion  rate, hs-CRP: h igh -sensitiv ity  C-reactive 
prote in, LDL: low -dens ity  lipopro te in , HDL: h igh -dens ity  lipop ro te in , LVEF: le ft 
ventricu lar e jection fraction, LVEDD: le ft ventricu lar end-diastolic diameter, LVESD: 
left ventricu lar end-systolic d iam eter, IVST: in terventricu lar septal thickness, PWT: 
posterio r wall thickness, LV mass: le ft ventricu la r mass.
with increased mortality and sudden death11. Likewise, 
HR correlates with mortality and cardiac events12. Also 
in this group, decreased HRR is an independent predic­
tor of mortality13.
720 P. Rio e t al.
T a b l e  2  Pre- and post-cardiac rehabilita tion data
Pre-CR Post-CR P-value
Standard deviation of th e  NN intervals (ms) 1 20 .7±40 .7 1 2 7 .6141 .5 0.019
Resting heart rate (min"') 7 1 .3 1 1 0 .7 6 9 .0 1 1 0 .9 0.015
Peak h eart rate (min-1) 138 .3 1 2 1 .0 1 4 1 .2121 .3 0.027
Basal systolic b lood pressure (mmHg) 121 .3 1 1 5 .0 119 .6 1 1 4 .8 0.311
Basal diastolic blood pressure (mmHg) 7 1 .5 1 9 .9 7 1 .6 1 1 0 .7 0.866
Peak systolic b lood pressure (mmHg) 171 .6 1 2 4 .9 170 .6 1 2 2 .6 0.654
Peak diastolic blood pressure (mmHg) 8 2 .3 1 1 1 .6 8 0 .5 1 1 0 .2 0.160
Heart rate reserve (min ') 6 7 .0120 .1 7 2 .2 1 2 0 .0 <0.001
Heart rate recovery (min"') 2 3 .8 1 1 2 .3 2 7 .1 1 1 2 .5 0.017
Cardiopulm onary testing  duration (min) 1 3 .5 1 3 .2 1 5 .3 1 2 .4 0.140
Peak oxygen consum ption (mL.kg.min'1) 2 5 .6 1 6 .8 2 7 .5 1 7 .2 0.001
Left ventricular ejection fraction (%) 5 4 .3 1 1 0 .3 5 4 .9 1 1 0 .4 0.192
E/A ratio 1.20 +  0.54 1 .0 6 1 0 .3 9 < 0.001
Values are mean ± SD.
T a b l e  3  Factors associated w ith  SDNN and HRR im provem ent
Variable Univariable analysis Multivariable analysis
Odds ratio (95% Cl) P-value Odds ratio (95% Cl) P-value
SDNN improvement
Obesity 2.444(1.077-5.544) 0.033 1.623 (0.402-6.543) 0.496
ESR 0.964(0.929-1.000) 0.047 0.911 (0.838-0.989) 0.027
LVEF > 40% 3.292(1.061-10.209) 0.039 7.879(2.753-17.351) 0.009
E/A ratio 2.667(1.140-6.243) 0.024 3.388(0.678-16.916) 0.137
SDNN < 1 0 0  ms 4.577(2.047-10.232) < 0.001 9.325 (1.775-48.978) 0.008
HRR improvement
Quit smoking 3.857(1.236-12.040) 0.020 4.323(1.136-16.454) 0.014
Abnormal HRR 18.655(2.412-144.276) 0.005 8.023(1.049-64.811) 0.035
LVEF < 35% 0.092 (0.011-0.772) 0.028 0.115(0.008-1.642) 0.111
SDNN: standard deviation o f the NN (regular R-R) intervals, ESR: erythrocyte sedimentation rate, LVEF: left ventricular ejection fraction, HHR: heart rate recovery.
A nother advantage of the autonomic nervous system 
evaluation through these three param eters is that they 
are easy to use and inexpensive. It may be a powerful 
and convenient tool for risk stratification and for m on­
itoring  the im provem ent after exercise tra in ing  in 
patients with coronary artery disease.
We m ust point out that rest HR and HR response was 
influenced by therapy, however, patients have been 
evaluated pre- and post-C R  w ith the same therapy, 
including beta blockers.
The CR programme was associated with a significant 
improvement in ANS function as assessed by the three 
param eters. In this study we observed a significant 
im provem ent of the resting HR (A 2.4 ± 11.0 m in -1; 
71.3 ±10.7 vs 69.0 + 10.9 m in -1' P =  0.015) and HRR 
{A 3 .3± 15.6 m im 1; 23.8±12.3 vs 27.1 ±12.5 m in-1,
P = 0.017). O ther studies previously demonstrated similar 
benefits after exercise training14,15. Ribeiro et al.15 in a well- 
designed prospective, randomized, controlled trial, found 
an improvement of resting HR by 5.5 m in 1 and an increase 
of HRR by 4 m in 1, in the training group, after 8 weeks of 
aerobic exercise, whereas the control group rem ained 
unchanged.
After exercise, the interval of HRR predom inantly 
results from parasym pathetic reactivation with sym pa­
thetic and non-autonom ic com ponents playing m inor 
roles. Exercise-based cardiac rehabilitation has been 
shown to reduce total mortality, cardiac mortality, hos­
pital adm issions16 and sudden death17. Therefore, one 
acceptable reason for the im provem ent of these ou t­
comes is the autonom ic function modification, mainly 
reflecting the an tiarrhy thm ic characteristic  o f the
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parasympathetic nervous system18. Other improvements 
of ANS, after exercise training, sharing similar patho­
physiological mechanisms, are the increased resting 
arterial baroreflex sensitivity, the decrease in muscle 
sympathetic nerve activity, and the reduced circulating 
catecholamines and angiotensin II levels19.
It is difficult to know if there is a clinical advantage in 
continuously improving the HRR or resting HR. Jouven 
et al.9 reported, in a cohort of asymptomatic working men, 
that a HRR < 25 bpm after the first minute of recovery 
provides a relative risk of 2.2 of sudden cardiac death 
compared with the highest-percentile HRR group 
(> 40 bpm). A RHR >75 bpm conferred a relative risk for 
sudden death of 3.9 compared with the lowest-percentile 
resting HR group (< 60 bpm). There seems to be a con­
tinuous relationship between prognostic and resting HR, 
with no observed threshold10. In this study, patients with 
decreased HRR achieved greater improvements in this 
parameter (< 12 bpm, n = 2 0 - 4  19.1 ± 14.1 ms;<25bpm, 
n = 72 -  d  9.8± 14.8 ms, P<0.001).
Another non-invasive parameter of ANS is HRV, 
which is the oscillation in the intervals between con­
secutive heartbeats. Commonly used time domain meas­
ures of HRV include standard deviation of normal R-R 
intervals (SDNN) which are also thought to be a marker 
of parasympathetic cardiac modulation. It is accepted 
that some therapies may improve outcomes by an 
increase of HRV. This is true for patients with heart 
failure who are subject to cardiac resynchronization 
therapy20 and to exercise training21. Significant improve­
ments in HRV in myocardial infarction patients with 
exercise were reported in some controlled trials22.
In the present study there was a significant improve­
m ent of the SDNN after CR (A 6.9 ± 34.5 ms; 
120.7±40.7m s vs 127.6±41.5 ms, P = 0.019), and 
patients with lower SDNN (< 100 ms, n = 51) had greater 
improvement (A 31.2 ± 50.0% vs -0.6 + 20.7%, P < 0.001). 
It is difficult to define a cut-off value of SDNN that 
defines impaired HRV and a threshold for no more 
improvement in outcomes. In this cohort high baseline 
HRV values correlate with less increase in SDNN and 
plateau has been previously described23.
Few studies have previously identified the character­
istics associated with ANS function modification. In our 
cohort, lower erythrocyte sedimentation rate, normal 
or mild systolic dysfunction and tobacco cessation were 
independent predictors of improved ANS.
In the literature an association is described between 
inflammation and autonomic dysfunction in CAD 
patients24,25and this combination seems to have a syner­
gistic effect26. The “inflammatory reflex” proposed by 
Tracey27 suggests that the activation of the vagal nerve 
leads to reduced production of inflammatory cytokines, 
thus the increase in vagal activation induced by exercise
training could be an important mechanism to improve 
the inflammatory status28. Whelton et al.29 found that an 
elevated resting heart rate is independently associated 
with elevated inflammatory biomarkers, such as high- 
sensitivity C-reactive protein, even after adjustment for 
physical activity levels. Our results, of better improve­
ment of SDNN in patients with CAD and with lower 
erythrocyte sedimentation rate, could reflect this finding 
as autonomic imbalance contributes to or is affected by 
increased inflammation.
In the same manner, heart failure is associated with 
more severe ANS dysfunction30, with sympathetic and 
renin-angiotensin-aldosterone hyperactivity. This could 
prevent greater improvements in HRV compared to 
patients with a normal systolic function. This result 
should not keep us from pushing because there is evi­
dence that the reduction of sympathetic activity by exer­
cise training in heart failure patients is associated with 
a better clinical outcome31'32.
Tobacco use is associated with autonomic imbalance- 
and decreased HRV33,34mainly due to nicotine exposure 
with catecholamine release and augmented sympathetic 
outflow35. In this sense, smoking cessation leads to an 
increase of HRV36. In our cohort of patients, smoking 
cessation was an independent predictor of HRR improve­
ment. The mechanism behind this fact is the same for 
HRV, since rapid decline in HR following exercise is 
largely due to parasympathetic restoration and both, 
exercise and smoking cessation in chronic smokers, 
increase vagal tone.
Medication may alter ANS function, particularly beta 
blockers, with clinical benefits37. As we m entioned 
before, all the patients were on beta blockers, with a 
stable dose during CR, thus the positive effects on ANS 
must have come from exercise training38.
The main finding of this work was that CR pro­
gramme generated a positive effect on ANS, mainly in 
those with autonomic dysfunction. CAD patients, in 
sinus rhythm, with lower systemic inflammation and 
with normal or mild systolic dysfunction were more 
likely to improve ANS function.
LIMITATIONS
This was a retrospective analysis of consecutively 
admitted CAD patients in sinus rhythm and the results 
reflect a single-centre experience without control group.
Smoking status was assessed by self-reporting rather 
than a biochemical method, in the group of smokers, 
the burden of tobacco use was not assessed. This fact 
could have clinical relevance because heavier smokers 
have greater autonomic dysfunction and isolated nico­
tine use deleteriously affects HRV39.
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CONCLUSION
Cardiac rehabilitation induced a positive modulation 
of the autonomic nervous system function in coronary 
artery disease patients. This benefit was more pro­
nounced in patients with autonomic nervous system 
dysfunction, objectively demonstrated by SDNN inferior
to 100 ms and abnormal heart rate recovery, and also 
with normal LV function to mild left ventricular systolic 
dysfunction and with lower erythrocyte sedimentation 
rate.
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